Share this article
Company Continues to Improve Gross Cash Position to Execute Business Plan
TORONTO, March 8, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the Company or SQI ) (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that 9,775,972 common share purchase warrants (the Warrants ) and 1,500,000 stock options (the Options ) have been exercised at exercise prices between $0.09 and $0.30 per common shares since January 1, 2021, resulting in gross proceeds of approximately $2.3 million to the Company (the Funding ). The Options were exercised by a director of the Company and the Warrants were exercised by non-insiders of the Company.
/PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid.
SQI Diagnostics Reports First Quarter 2021 Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
SQI Diagnostics Announces New Corporate Website
News provided by
Share this article
New Website Provides Essential Information on Company s Strategic Initiative
TORONTO, Feb. 18, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the Company or SQI ) (TSX-V: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today is proud to announce the launch of its newly redesigned website at https://www.sqidiagnostics.com. The revamped site features a streamlined, modern design, improved functionality and easy access to essential information to help educate all stakeholders about the Company and its new strategic vision, including the latest product development and investor information.
SQI Diagnostics Reports Fourth Quarter and Fiscal 2020 Results
News provided by
Share this article
Share this article
TORONTO, Jan. 27, 2021 /PRNewswire/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today reported its financial and operational results for the fourth quarter and fiscal year ended September 30, 2020.
Q4 2020 Financial Highlights
Sales were $0.3M, compared to $0.6M in Q4 2019 due to a combination of the absence of platform sales in the current quarter and the negative impacts of COVID-19 on the business and operations of the Company, as one of our customers temporarily suspended operations, which adversely impacted kit sales, lower service revenue due to the delay of a project with a major customer